Autopsy report · NCT05571540

Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL

“The PI decides to stop.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Kunming Hope of Health Hospital

Sponsor type

University, hospital or other

Conditions

B-cell Acute Lymphoblastic Leukemia; B-ALL

Interventions

U-CAR-T Cells (LstCAR019)

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Cross-sectional Study on a Given Day Within the Paris Saint-Joseph Hospital Group
  “The PI decided it.” (68% match in meaning)
• Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
  “PI decided not to proceed” (68% match in meaning)
• Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
  “Departure of PI” (68% match in meaning)
• Comparison of Low-dose Epidural With Intravenous Narcotic Versus Intravenous Narcotic Alone
  “terminated by PI” (67% match in meaning)
• Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
  “PI decided to stop the study” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.